What is Biopac India Corporation Ltd (532330) share price return in the past 10 years?

Biopac India Corporation Ltd share price has declined -17.1% annually (CAGR) over the past ten years.

What is the share price of Biopac India Corporation Ltd (532330)?

Company share prices are keep on changing according to the market conditions. The current trading price of Biopac India Corporation Ltd (532330) on 15-Jan-2021 18:59:26 at 18:59 is 1.99.

What is the P/E ratio of Biopac India Corporation?

The latest standalone P/E ratio of Biopac India Corporation as of 15-Jan-2021 is 0.00.

What is the P/B ratio of Biopac India Corporation Ltd (532330)?

The latest standalone P/B ratio of Biopac India Corporation Ltd (532330) as of 15-Jan-2021 is -0.18.

What is the 52-week high and low of Biopac India Corporation Ltd (532330)?

The 52-week high of Biopac India Corporation Ltd (532330) is Rs. 2.01 and the 52-week low is Rs. 1.83.

Biopac India Corporation Ltd (532330) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Biopac India Corporation Ltd (532330)
Brand: Biopac India Corporation

Biopac India Corporation Ltd (532330)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532330 NSE: Plastic Products | Small Cap | Biopac India Corpn. Share Price

Biopac India Corporation Ltd (532330)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532330 NSE: Plastic Products | Small Cap | Biopac India Corpn. Share Price

Key Metrics

Valuation Multiples

Market Cap

₹3 Cr.

Current Price

₹2

52-Week Low / High

₹2 / 2

TTM EPS

₹-4.8

TTM Sales

₹1.5 Cr.

Book Value per Share

₹-11.3

P/E Ratio

0.00

Industry PE

Price to Book (P/B)

-0.18

In line with its 5-year historical median

Price to Sales (P/S)

2.31

In line with its 5-year historical median

EV/EBITDA

-14.45

In line with its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-387.41%

Underperforms industry median

Return on Capital Employed (ROCE)

-46.78%

Underperforms industry median

Return on Assets (ROA)

-42.41%

Operating Profit Margin

-65.1%

Net Profit Margin

-114.22%

Gross Profit Margin

-73.1%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-57.13%

Operating Profit Growth (1 Year)

-280.55%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

49.65%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹-37 Cr.

Equity

₹17.3 Cr.

Face Value

₹10

All Time Low / High

₹1.47 / 54.05

Biopac India Corporation stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Biopac India Corporation Ltd a good quality company?

Biopac India Corporation Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Biopac India Corporation Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Biopac India Corporation Ltd vs industry peers?

Biopac India Corporation Ltd revenue CAGR is -17.29%, compared to the industry median CAGR of 4.71%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Biopac India Corporation Ltd?

Promoters hold 49.65% of the Biopac India Corporation Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Biopac India Corporation Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -17.1% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	7.9%	15.8%	3%	4.2%	8.2%	6%	9.3%	8.9%	3.6%	-46.8%	-
Value Creation Index ⓘ	-0.4	0.1	-0.8	-0.7	-0.4	-0.6	-0.3	-0.4	-0.7	NA	-
Growth Parameters ⓘ
Sales ⓘ	41.7	38.1	38.1	45.6	52.3	58.6	52.1	47.8	47.2	20.2	1
Sales YoY Gr.	-	-8.5%	0%	19.6%	14.7%	12%	-11%	-8.3%	-1.2%	-57.1%	-
Adj EPS ⓘ	0	0.9	0.1	0.1	0.6	0.5	0	0.1	-1.6	-13.4	-4.8
YoY Gr.	-	4400%	-88.9%	0%	530%	-19.1%	-94.1%	100%	-2716.7%	NA	-
BVPS (₹) ⓘ	9.4	10.3	10.4	10.5	11.1	11.6	11.7	11.7	10.2	-3.2	-11.3
Adj Net Profit ⓘ	0	1.6	0.2	0.2	1.1	0.9	0.1	0.1	-2.7	-23.1	-8
Cash Flow from Ops. ⓘ	13.2	9.1	4.7	4.8	1.2	14.8	10.6	7.6	-4.5	13	-
Debt/CF from Ops. ⓘ	0.8	0.6	0.4	2.6	15.5	1.8	3.1	3.9	-7.8	2.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-7.7%	-17.3%	-27%	-57.1%
Adj EPS ⓘ	-306.1%	-284.3%	-864.4%	NA
BVPSⓘ	-188.9%	-178.1%	-165.2%	-131.9%
Share Price	-17.1%	-	-	-

Key Financial Parameters ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	0.2	9.2	1	1	5.8	4.5	0.3	0.5	-14.3	-387.4	65.3
Op. Profit Mgn % ⓘ	15.2	22.2	12.4	11.4	14.6	12.6	19.3	21	15.5	-65.1	-85.1
Net Profit Mgn % ⓘ	0.1	4.1	0.5	0.4	2.1	1.5	0.1	0.2	-5.7	-114.2	-554.8
Debt to Equity ⓘ	0.7	0.3	0.1	0.7	1	1.4	1.6	1.5	2	-5.9	-
Working Cap Days ⓘ	111	61	51	54	75	93	93	84	125	231	20
Cash Conv. Cycle ⓘ	51	25	18	11	16	10	7	24	57	131	-1,268

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	41.65	38.10	38.10	45.58	52.30	58.56	52.10	47.77	47.21	20.24
Operating Expenses ⓘ +	35.32	29.65	33.38	40.40	44.67	51.16	42.05	37.74	39.91	33.42
Manufacturing Costs	6.77	7.02	8.20	9.54	9.06	14.13	9.95	3.91	4.86	4.03
Material Costs	23.76	17.01	19.40	23.74	29.28	28.04	22.68	22.60	23.69	17.66
Employee Cost	2.68	3.18	3.12	4.42	4.38	5.18	5.77	6.16	6.21	8.48
Other Costs ⓘ	2.11	2.43	2.66	2.70	1.94	3.81	3.65	5.06	5.14	3.24
Operating Profit ⓘ	6.33	8.46	4.72	5.18	7.63	7.40	10.04	10.04	7.30	-13.18
Operating Profit Margin (%)	15.2%	22.2%	12.4%	11.4%	14.6%	12.6%	19.3%	21.0%	15.5%	-65.1%
Other Income ⓘ +	0.08	0.01	0.01	0.06	0.02	0.11	0.03	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2.24	0.73	0.60	0.77	1.70	1.74	3.89	4.27	4.87	4.52
Depreciation ⓘ	4	4.52	4.10	4.17	4.85	4.93	5.44	5.49	5.46	5.44
Profit Before Tax ⓘ	0.16	3.22	0.04	0.29	1.09	0.84	0.75	0.28	-3.02	-23.13
Tax ⓘ	0.13	1.66	-0.13	0.10	0.01	-0.04	0.70	0.18	-0.32	-0.01
Profit After Tax	0.03	1.56	0.17	0.20	1.08	0.88	0.05	0.10	-2.70	-23.12
PAT Margin (%)	0.1%	4.1%	0.5%	0.4%	2.1%	1.5%	0.1%	0.2%	-5.7%	-114.0%
Adjusted EPS (₹)	0.0	0.9	0.1	0.1	0.6	0.5	0.0	0.1	-1.6	-13.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Biopac India Corpn. - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	16.19	17.75	17.93	18.12	19.20	20.08	20.13	20.23	17.53	-5.59
Share Capital ⓘ	17.25	17.25	17.25	17.25	17.25	17.25	17.25	17.25	17.25	17.25
Reserves ⓘ	-1.06	0.50	0.68	0.87	1.95	2.83	2.88	2.98	0.28	-22.84
Debt +	10.79	5.33	1.95	12.25	18.92	22.92	24.84	23.24	33.29	24.68
Long Term Debt	10.79	1.95	1.35	9.22	12.57	18.46	18.08	16.54	28.44	21.41
Short Term Debt	0	3.38	0.60	3.02	6.35	4.46	6.75	6.70	4.84	3.26
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	3.65	2.09	2.99	5.26	4.75	6.82	5.56	6.31	8.60	9.06
Others Liabilities ⓘ	1.92	2.05	2.36	2.87	3.03	15.51	10.98	10.16	5.72	15.75
Total Liabilities ⓘ	32.55	27.22	25.22	38.50	45.90	65.33	61.51	59.94	65.14	43.90
Fixed Assets
Net Fixed Assets ⓘ +	23.85	21.96	18.32	28.14	29.99	25.17	50.50	46.51	41.62	36.37
Gross Block	42.41	45.06	45.51	59.42	66.12	66.23	96.96	46.51	47.04	47.23
Accumulated Depreciation	18.56	23.09	27.19	31.28	36.13	41.06	46.46	0	5.42	10.86
CWIP ⓘ	0.11	0	0.15	0.46	0.47	21.74	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	6.45	3.74	2.76	5.72	6.54	5.18	7	9.27	14.43	6.35
Trade Receivables	1.68	1.04	2.31	1.42	3.10	2.66	2.71	3.08	7.41	0.86
Cash Equivalents	0.06	-0.11	0.69	1.18	0.50	0.28	0.12	0.18	0.39	0.08
Others Assets ⓘ	0.40	0.59	1	1.58	5.30	10.29	1.18	0.89	1.28	0.24
Total Assets ⓘ	32.55	27.22	25.22	38.50	45.90	65.33	61.51	59.94	65.14	43.90

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	13.20	9.12	4.73	4.76	1.22	14.81	10.63	7.58	-4.50	13
PBT ⓘ	0.16	3.22	0.04	0.29	1.09	0.84	0.75	0.28	-3.02	-23.13
Adjustment ⓘ	6.25	5.25	4.69	4.79	6.54	6.67	9.29	9.76	10.33	9.95
Changes in Working Capital ⓘ	6.83	1.31	0.66	-0.33	-6.3	7.5	1.06	-2.26	-11.75	26.18
Tax Paid ⓘ	-0.04	-0.66	-0.66	0	-0.11	-0.19	-0.47	-0.19	-0.06	-0
Cash Flow From Investing Activity ⓘ +	-4.67	-2.65	-0.60	-14.31	-6.71	-21.38	-8.99	-1.51	-0.57	-0.19
Capex	-4.67	-2.65	-0.60	-14.31	-6.71	-21.38	-8.99	-1.51	-0.57	-0.19
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-9.52	-6.10	-3.31	9.67	4.98	6.54	-1.80	-5.97	5.23	-13.12
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-2.23	-0.64	-0.60	-0.63	-1.69	-1.80	-3.72	-4.37	-4.82	-4.52
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-7.29	-5.47	-2.72	10.30	6.67	8.34	1.92	-1.60	10.05	-8.61
Net Cash Flow ⓘ	-0.99	0.36	0.82	0.11	-0.51	-0.04	-0.16	0.11	0.16	-0.30

Financial Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	0.2	9.18	0.97	1.1	5.79	4.46	0.26	0.49	-14.3	N/A
ROCE (%)	7.86	15.77	2.96	4.24	8.15	6.04	9.28	8.89	3.61	N/A
Asset Turnover Ratio	1.19	1.39	1.57	1.57	1.37	1.16	0.9	0.86	0.85	0.44
PAT to CFO Conversion(x)	440	5.85	27.82	23.8	1.13	16.83	212.6	75.8	N/A	N/A
Working Capital Days
Receivable Days	10.40	12	14.80	13.60	14.30	16.30	17.10	20.20	36.10	62.40
Inventory Days	96.30	44.90	28.80	30.90	38.80	33	38.90	56.90	81.50	156.70
Payable Days	78.90	61.50	47.80	63.50	62.40	75.30	99.70	95.90	114.90	182.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

20.14

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biopac India Corporation Ltd FAQs

The current trading price of Biopac India Corpn. on 15-Jan-2021 18:59 is ₹1.99.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 14-Jan-2021 the market cap of Biopac India Corpn. stood at ₹3.43 Cr

The latest P/E ratio of Biopac India Corpn. as of 14-Jan-2021 is 0.00.

The latest P/B ratio of Biopac India Corpn. as of 14-Jan-2021 is -0.18.

The 52-week high of Biopac India Corpn. is ₹2.01 and the 52-week low is ₹1.83.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biopac India Corpn. is ₹1.48 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biopac India Corporation Ltd is a below average quality company.

The key valuation ratios of Biopac India Corporation Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biopac India Corporation Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Biopac India Corporation Ltd

Biopac India Corporation Ltd.,formerly a division of Pushpa Implex Private Ltd , started its manufacturing business in the year 1998. The company is listed on the Mumbai Stock Exchange and has a Paid-up Equity Capital of Rs.160 million (approx. $ 3.5 millions). A 30,000 sq.ft. ultra modern plant of the company is located at Silvassa which is approximately 170 kms. North West of Mumbai.

The company employs about 80 people who take care of various functions like production, sales, logistics, finance, accounts and administration. The company produces world class foam polystyrene products and plans to be a global player in this business.

The company has also moved into making general purpose polystyrene foam cups, bowls, plates and so on. This was intended to be a substitute for the present products in the market, which were only disposable plates made of paper and rigid plastic. The potential market for higher quality disposable plates and takeout containers appears to have been behind the foray.

The company came with a public issue in April 2000 with initial public offer of equity for 4,30,000 shares.

Product range of the company includes:Consumer Products:

Dinnerware
Plates
Soup Bowls
Serving Bowls
Serving Trays
Cups
Readymade Lunch Tray for dosa, mini meals, pao bhaji

Take Out Food Containers

Flat-Type Containers/Serving Bowls
Cup-type Containers
Box-type (hinged) & Tray Containers

Industrial Products:

Readymade conveyance and packaging for:

Poultry products (like egg trays, frozen chicken packing)
Orchard products (like apples, mangoes, oranges and strawberries)
Seafood export
Icecream, yoghurt, and shrikhand cups
Instant noodle packs, soup containers, Pre-cast moulds for PCC tiles

Customised Products (Biofoam Sheets)

Uncoated in thickness 1mm to 15mm.
Polystyrene coating on Top side in thickness 2mm to 5mm.
Polystyrene coating on Both sides in thickness 4mm to 8mm

Biopac India Corporation Ltd (532330)

Biopac India Corporation Ltd (532330)

Biopac India Corporation stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Biopac India Corpn. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biopac India Corporation Ltd FAQs

About Biopac India Corporation Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Biopac India Corporation Ltd (532330)

Biopac India Corporation Ltd (532330)

Biopac India Corporation stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Biopac India Corpn. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biopac India Corporation Ltd FAQs

What is the share price of Biopac India Corpn.?

What is the market cap of Biopac India Corpn.?

What is the P/E ratio of Biopac India Corpn.?

What is the P/B ratio of Biopac India Corpn.?

What is the 52-week high and low of Biopac India Corpn.?

What is the TTM revenue of Biopac India Corpn.?

Is Biopac India Corporation Ltd a good quality company?

Is Biopac India Corporation Ltd undervalued or overvalued?

Is Biopac India Corporation Ltd a good buy now?

About Biopac India Corporation Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.